Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Congenital Diaphragm Hernia

Key facts

Sponsor

Anthony Johnson

Principal Investigator

Anthony Johnson, DO

The University of Texas Health Science Center, Houston

Intervention

FETO therapy(device)

Enrollment

22 enrolled

Eligibility

18-45 years · FEMALE

Timeline

2015 – 2026

Study locations (1)

• The University of Texas Health Science Center at Houston, Houston, Texas, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Congenital diaphragmatic hernia

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT05962346
  Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
  Mauro H. Schenone
• RECRUITINGNANCT05354505
  Fetal Endoscopic Tracheal Occlusion (FETO) Trial for Congenital Diaphragmatic Hernia (CDH)
  Vincent Duron
• RECRUITINGPHASE4NCT05213676
  De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
  The University of Texas Health Science Center, Houston
• RECRUITINGPHASE3NCT07187206
  Safety and Efficacy of FETO in CDH Phase III
  Children's Hospital Medical Center, Cincinnati
• RECRUITINGNANCT07166172
  Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH
  Johns Hopkins University
• RECRUITINGNANCT06884423
  Safety and Efficacy of FETO in CDH: A Phase III Trial
  Holly L Hedrick, MD
• RECRUITINGNANCT06739356
  North American Fetal Therapy Network for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia
  The University of Texas Health Science Center, Houston
• RECRUITINGNANCT03138863
  Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO)
  Rodrigo Ruano

See all trials for Congenital diaphragmatic hernia →